Clinical Trial Update: Mesenchymal Stem Cells and Myocardial Ischemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating mesenchymal stem cells for chronic myocardial ischemia and left ventricular dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Dysfunction
• Myocardial Ischemia

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Chronic Myocardial Ischemia, Left Ventricular Dysfunction | Phase 1, Phase 2 | Status: COMPLETED